Abstract:HCA-7 human colorectal cancer cells were transfected with miRNA precursor forms, pre-miR-143 or pre-miR-145; or c-Myc siRNA or scrambled oligonucleotides using Lipofectamine.Colon cancer cell or colonic fibroblast EGFR was activated with EGF or inhibited with C225 anti-EGFR antibodies.Western blotting was used to assess G1 cell cycle regulators: c-Myc, cdk6, cyclin D2, E2F3 and pRb.Northern blotting and real time PCR were used to measure miR-143 and miR-145.Cell proliferation and DNA synthesis were measured by WST-1 and BrdU incorporation, respectively.Results: Northern blotting confirmed low levels of miR-143 and miR-145 in human colon cancers and cell lines.As in the case of human cancers, miR-143 and miR-145 were down-regulated 90% in colonic tumors of mice with wt EGFR.In striking contrast, these miRNA were increased 4-5-fold in tumors from Wa2 Egfr mice.Wa2 mutations nearly abolish receptor kinase activity In Vitro.Up-regulations of pre-miR-143 or pre-miR-145 by transfection caused 60-70% reduction in proliferation and inhibited DNA synthesis by 80-90% in HCT116 cells, consistent with a tumor suppressor role for these miRNA.Modulating EGFR signals caused parallel changes in c-Myc, while inducing inverse changes in miR-143 and miR-145 in cancer cells (C225-treated) and fibroblasts (EGF-treated).c-Myc siRNA knock-down also increased miR-143 and miR-145 by 50-95% in cancer cells, while decreasing c-Myc ~90%, suggesting c-Myc mediates EGFR suppression of these miRNAs.Compared to control, EGF increased cdk6, pRb and E2F3, whereas C225 antibodies reduced these proteins in cancer cells, identifying these G1 regulators as EGFR targets.In contrast, pre-miR-143 and pre-miR-145 reduced these G1 regulators by 30-60% in HCT116 cells, suggesting they are also functional targets of miR-143 and miR-145.Conclusion: These studies suggest that EGFR proliferation is mediated by c-Myc via inhibition of miR-143 and miR-145.Furthermore, we have demonstrated for the first time that these miRNA negatively control G1 cell cycle regulators.

[EGFR-ERK Signaling Pathway Down-Regulates Mirna-145 in Lung Cancer Cells].

Abnormal activation of the EGFR signaling pathway mediates the downregulation of miR‑145 through the ERK1/2 in non-small cell lung cancer.

Biomarker of Pulmonary Inflammatory Response in LUAD: Mir-584-5p Targets RAB23 to Suppress Inflammation Induced by LPS in A549 Cells.

Mir-145-5p Inhibits Epithelial-Mesenchymal Transition Via the JNK Signaling Pathway by Targeting MAP3K1 in Non-Small Cell Lung Cancer Cells.

1069 MicroRNA-143 is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer

Epidermal Growth Factor Receptor Expression Affects Proliferation and Apoptosis in Non-Small Cell Lung Cancer Cells Via the Extracellular Signal-Regulated Kinase/microrna 200a Signaling Pathway.

Mir-150 Promotes the Proliferation and Migration of Lung Cancer Cells by Targeting SRC Kinase Signalling Inhibitor 1.

1070 Differential Expression of MicroRNAs in Plasma of Colorectal Cancer Patients: A Potential Marker for Colorectal Cancer Screening

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

Downregulation of Mir-138 Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

Decreased Mir-124 Contributes to the Epithelial-Mesenchymal Transition Phenotype Formation of Lung Adenocarcinoma Cells Via Targeting Enhancer of Zeste Homolog 2.

Up-Regulation Of Mir-182-5p Predicts Poor Prognosis In Patients With Lung Cancer And Associates With Tumor Cell Growth And Migration

EGFR-AS1 Promotes Nonsmall Cell Lung Cancer (NSCLC) Progression via Downregulating the miR-524-5p/DRAM1 Axis and Inhibiting Autophagic Lysosomal Degradation

In-silico Analysis of EGFR-associated Microrna Signature in Cancer.

Downregulation of Mir‐3127‐5p Promotes Epithelial‐mesenchymal Transition Via FZD4 Regulation of Wnt/β‐catenin Signaling in Non‐small‐cell Lung Cancer

Co-targeting of EGFR by Co-Expressed Mirna-193A-3p/−5p in Lung Cancer

Effects of Mir‑138‑5p and Mir‑204‑5p on the Migration and Proliferation of Gastric Cancer Cells by Targeting EGFR.

Exploring Microrna-Mediated Alteration of EGFR Signaling Pathway in Non-Small Cell Lung Cancer Using an Mrna:Mirna Regression Model Supported by Target Prediction Databases.

MiR-145 Regulates PAK4 Via the MAPK Pathway and Exhibits an Antitumor Effect in Human Colon Cells.

Mir-186-5p Promotes Cell Growth, Migration and Invasion of Lung Adenocarcinoma by Targeting PTEN

Mir-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells